RE: Delisting14 Apr 2020 07:12
Here you go:
Mon, 13th Jan 2020 07:00
RNS Number : 5180Z
Tiziana Life Sciences PLC
13 January 2020
Tiziana Life Science Plc (the "Company")
Proposed Cancellation from AIM
New York/London, 13 January 2020 - Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS), a biotechnology company focusing on the discovery and development of innovative therapeutics for inflammation and oncology indications, announces that it has appointed advisers in relation to an intended redomicile of the Company to Bermuda which is anticipated to occur by Q2-2020, as a consequence of the redomicile the Company will not be seeking to re-admit its ordinary shares on AIM and will therefore seek shareholder consent for its shares to be cancelled from AIM when the redomicile occurs. A further announcement will be made in due course.
Furthermore, the Company intends to cancel its ADR program and have its Bermuda common shares listed on Nasdaq.
The Company is today attending the J.P. Morgan Healthcare Conference in San Francisco, a copy of the investor presentation that is being used by the Company is available for download from its website at www.tizianalifesciences.com.